Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116246786 | 11624678 | 6 | F | 20121207 | 20160601 | 20151013 | 20160728 | EXP | US-MLMSERVICE-20150923-0030800 | US-009507513-1510USA002764 | MERCK | 69.00 | YR | F | Y | 113.00000 | KG | 20160728 | OT | GB | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116246786 | 11624678 | 1 | PS | PRINIVIL | LISINOPRIL | 1 | Oral | 20 MG PO, QD | Y | 19558 | 20 | MG | TABLET | QD | |||||
| 116246786 | 11624678 | 2 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 1 G, BID | Y | 0 | 1 | G | BID | ||||||
| 116246786 | 11624678 | 3 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 750 MG, BID | Y | 0 | 750 | MG | BID | ||||||
| 116246786 | 11624678 | 4 | SS | VANCOMYCIN | VANCOMYCIN | 1 | 12 G SINGLE, INJECTED INTO THE TIBIAL AND FEMORAL MOLDS | Y | 0 | 12 | G | 1X | |||||||
| 116246786 | 11624678 | 5 | SS | VANCOMYCIN | VANCOMYCIN | 1 | 4 G SINGLE, INJECTED INTO THE TIBIAL AND FEMORAL MOLDS | Y | 0 | 4 | G | 1X | |||||||
| 116246786 | 11624678 | 6 | SS | TOBRAMYCIN. | TOBRAMYCIN | 1 | 10.8 G SINGLE, INJECTED INTO THE TIBIAL AND FEMORAL MOLDS | U | 0 | 10.8 | G | 1X | |||||||
| 116246786 | 11624678 | 7 | SS | TOBRAMYCIN. | TOBRAMYCIN | 1 | 3.6 G SINGLE, INJECTED INTO THE TIBIAL AND FEMORAL MOLDS | U | 0 | 3.6 | G | 1X | |||||||
| 116246786 | 11624678 | 8 | SS | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 3375 G IV, Q6H | Y | 0 | Q6H | ||||||||
| 116246786 | 11624678 | 9 | C | RIFAMPIN. | RIFAMPIN | 1 | Oral | UNK | 0 | ||||||||||
| 116246786 | 11624678 | 10 | C | SOLIFENACIN SUCCINATE. | SOLIFENACIN SUCCINATE | 1 | U | 0 | |||||||||||
| 116246786 | 11624678 | 11 | C | acetaminophen (+) hydrocodone bitartrate | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | U | 0 | |||||||||||
| 116246786 | 11624678 | 12 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | U | 0 | |||||||||||
| 116246786 | 11624678 | 13 | C | DULOXETINE HYDROCHLORIDE. | DULOXETINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 116246786 | 11624678 | 14 | C | PAROXETINE. | PAROXETINE | 1 | U | 0 | |||||||||||
| 116246786 | 11624678 | 15 | C | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | U | 0 | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116246786 | 11624678 | 1 | Arthritis infective |
| 116246786 | 11624678 | 2 | Arthritis infective |
| 116246786 | 11624678 | 6 | Arthritis infective |
| 116246786 | 11624678 | 7 | Knee arthroplasty |
| 116246786 | 11624678 | 8 | Arthritis infective |
| 116246786 | 11624678 | 9 | Arthritis infective |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116246786 | 11624678 | OT |
| 116246786 | 11624678 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116246786 | 11624678 | Acute kidney injury | |
| 116246786 | 11624678 | Blood pressure decreased | |
| 116246786 | 11624678 | Drug clearance decreased | |
| 116246786 | 11624678 | Drug level increased | |
| 116246786 | 11624678 | Haemoglobin increased | |
| 116246786 | 11624678 | Hypotension | |
| 116246786 | 11624678 | Renal tubular necrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |